Skip to main content
. 2022 Nov 14;31(2):88–96. doi: 10.1177/02184923221138504

Table 4.

Comparison of the primary and secondary outcomes between control and ERAS groups.

Primary and secondary outcomes Control group
n = 103
ERACS
(intervention group)
n = 100
Comparison between groups
Time to extubation (hours) 14.72 ± 33.15
[2–313]
Med = 9 (5–13)
6.69 ± 1.64
[4–15]
Med = 6 (6–8)
M-W p < 0.001
ANCOVA p = 0.022
QR p = 0.003
Hospital length of stay (days). 8.88 ± 3.50
[4–25]
Med = 8 (7–9)
5.13 ± 1.34
[3–11]
Med = 5 (4–6)
M-W p < 0.001
ANCOVA p < 0.022
QR p < 0.003
95% confidence interval estimated using bootstrapping method 78.26–9.60 4.95–5.05
Time to ambulate
(Sitting at the edge of the bed) (hours)
40.43 ± 46.70
[13–313]
Med = 23 (21–40)
9.78 ± 2.03
[7–20]
Med = 10 (8–11)
M-W p < 0.001
ANCOVA p < 0.001
QR p < 0.001
95% confidence interval estimated using bootstrapping method 22.02–23.98 9.16–10.84
Opioid consumption in ICU milligram morphine equivalent (MMI) 50.58 ± 11.93
[30–100]
Med = 50 (40–55)
11.58 ± 4.43
[5–25]
Med = 10 (10–15)
M-W p < 0.001
ANCOVA p < 0.001
QR p < 0.001